We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Microbial insecticides in Iran: History, current status, challenges and perspective.
Journal of Invertebrate Pathology 2018 Februrary 22
Biological control programs with arthropods have been in practice in Iran since the 1930s. However, development and registration of microbial biopesticides is much more recent. Currently, about 15 biopesticide products are registered or pending registration for commercial use on various crops. Products based on Bacillus thuringiensis subsp. kurstaki are most widely sold for lepidopteran pest control, followed by B. thuringiensis subsp. isralensis against dipteran pests in vector control programs. Additionally, mycoinsecticides based on Lecanicillium lecanii and Beauveria bassiana, against various arthropod pests, and a mycofungicide based on Trichoderma harzianum for controlling soilborne diseases are also registered. In Iran, the national Plant Protection Organization (PPO) manages regulation of microbial pesticides and the Pesticide Supervision Board within the PPO oversees registration of all pesticides. Currently, two Iranian companies produce microbial pesticides and two more companies are approved to start production in the near future. We review the history of microbial control of arthropod pests in Iran with examples of sustainable agricultural practices, the current status of the market and registration procedures for microbial pesticides, along with the challenges and opportunities for the advancement of microbial control in Iran.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app